Multi-arm Optimization of Stroke Thrombolysis
American College of Cardiology
SEPTEMBER 10, 2024
The goal of the MOST trial was to evaluate argatroban vs. eptifibatide vs. placebo among patients with acute ischemic stroke treated with intravenous thrombolytic therapy.
Let's personalize your content